Intelligence · Patents
Patents expiring in 2031
Annual patent cliff calendar for 2031 — US pharmaceutical patents by expiration date.
- Patents
- 902
Quick answer
902 indexed pharmaceutical patents have expiration dates in 2031. Browse by soonest expiry with links to assignee companies and related drugs.
-
EP 2336066
Spule mit darauf aufgewickelter beschichteter Folienbahn
granted -
US 7968545
Compositions useful as inhibitors of voltage-gated ion channels
granted -
US 7968716
Caspase inhibitors and uses thereof
granted -
US 7968117
Externally triggered microcapsules
granted -
US 7968298
Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication
granted -
US 7968115
Liposomal curcumin for treatment of cancer
granted -
US 7968559
Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
granted -
US 7968080
Somatostatin analogs with inhibitory activity to growth hormone release
granted -
US 7968749
Process for preparing and drying solid rasagiline base
granted -
US 7968714
Optical determination of glucose utilizing boronic acid adducts
granted -
US 7968726
Methods of preparing imidazole-based bicyclic compounds
granted -
US 7968664
Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof
granted -
US 7968615
Polymerizable monomer, polymerizable composition and dental material
granted -
US 7968511
Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
granted -
CA 2785117
SYSTEME THERAPEUTIQUE TRANSDERMIQUE SERVANT A ADMINISTRER DE LA RIVASTIGMINE OU SES DERIVES
granted -
US 7973038
Modulators of ATP-binding cassette transporters
granted -
US 7973162
Modulators of muscarinic receptors
granted -
US 7972606
T24 antigen for immunodiagnosis of Taenia solium cysticercosis
granted -
US 7972661
Electrospraying method with conductivity control
granted -
US 7972601
Method of promoting delivery of an antioxidant agent to a cell expression neuroligin
granted -
US 7972793
Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
granted -
US 7973163
Fused quinoline derivative and use thereof
granted -
US 7973045
Anhydrous form of dasatinib and process for preparation thereof
granted -
US 7972543
Process for producing microsphere with use of metal substrate having through-hole
granted -
US 7973075
Kainate receptor-selective epimeric analogs of dysiherbaine
granted -
US 7973069
Methods for treating hepatitis C
granted -
US 7973169
Modulators of ATP-Binding Cassette transporters
granted -
US 7973020
Compositions and methods for inhibiting expression of a gene from the ebola virus
granted -
US 7973057
Thalidomide analogs
granted -
US 7972821
Production of functional proteins: balance of shear stress and gravity
granted -
US 7972813
Tetrodotoxin-resistant sodium channel alpha subunit
granted -
US 7972854
Methods and compositions for targeted cleavage and recombination
granted -
US 7972598
VEGF-binding fusion proteins and therapeutic uses thereof
granted -
EP 2340815
Verfahren und Vorrichtung zur Herstellung einer überlappenden Schutzfolie für ein transdermales therapeutisches System
granted -
US 7977427
Method involving 1-benzotriazolyl carbonate esters of polymers
granted -
US 7976834
Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles
granted -
US 7976743
Gas-containing liposomes
granted -
US 7976832
Active topical skin protectants containing amines, polyalkenimines and /or derivatives
granted -
US 7977468
Chromosome 3p21.3 genes are tumor suppressors
granted -
US 7977359
5-lipdxygenase-activating protein (FLAP) inhibitors
granted -
US 7977457
Fusion proteins, uses thereof and processes for producing same
granted -
US 7977322
Modulators of ATP-binding cassette transporters
granted -
US 7977312
Compositions and methods for increasing bone mineralization
granted -
US 7976936
Endoprostheses
granted -
US 7976853
Process for producing coated preparation
granted -
US 7976851
Non-toxic biofilm inhibitor
granted -
US 7976868
Liposomes comprising duramycin and anti-viral agents
granted -
US 7977320
Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents
granted
Frequently asked questions
How many pharma patents expire in 2031?
902 published patents in our USPTO index have expiration dates falling in calendar year 2031.